04-144
Showing 26 - 50 of 2,487
Myocardial Fibrosis Trial in Nanjing (68Ga/18F-FAPI-04)
Recruiting
- Myocardial Fibrosis
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
May 11, 2023
Gastric Cancer Trial in Shanghai (68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT)
Recruiting
- Gastric Cancer
- 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT
-
Shanghai, Shanghai, ChinaShanghai Ruijin Hospital
Dec 2, 2022
HIV Trial in United States (N332-GT5 gp140 (IM, Bolus), N332-GT5 gp140 (IM, Fractioned), N332-GT5 gp140 (SC, Bolus))
Not yet recruiting
- HIV
- N332-GT5 gp140 (IM, Bolus)
- +7 more
-
San Francisco, California
- +7 more
Sep 8, 2023
Chronic Kidney Diseases, Magnetic Resonance Imaging Trial in Suzhou (TQ-B3525)
Not yet recruiting
- Chronic Kidney Diseases
- Magnetic Resonance Imaging
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jan 10, 2023
Unresectable Melanoma, Metastatic Melanoma Trial in Orlando, Louisville, New York (Lifileucel)
Available
- Unresectable Melanoma
- Metastatic Melanoma
- Lifileucel
-
Orlando, Florida
- +2 more
Jul 19, 2022
Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))
Recruiting
- Alpha1-Antitrypsin Deficiency
- Alpha-1 15%
- Liquid Alpha1-Proteinase Inhibitor (Human)
-
Gainesville, Florida
- +5 more
Jan 13, 2023
Rectal Cancer Stage III Trial in Germany (Oxaliplatin, 85 mg/m2, 5FU; 2400 mg/m2, 5FU, 250 mg/m2)
Recruiting
- Rectal Cancer Stage III
- Oxaliplatin, 85 mg/m2
- +11 more
-
Esslingen, Baden-Wuerttemberg, Germany
- +75 more
Dec 13, 2022
Malaria Trial (Ganaplacide, Lumefantrine, Efavirenz)
Completed
- Malaria
- Ganaplacide
- +2 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Jan 11, 2023
Preschool Children Trial (Combined Movement and Storytelling Intervention)
Not yet recruiting
- Preschool Children
- Combined Movement and Storytelling Intervention
- (no location specified)
Aug 25, 2023
Growth Hormone Deficiency in Children Trial in Worldwide (Somapacitan, Norditropin®)
Active, not recruiting
- Growth Hormone Deficiency in Children
-
Birmingham, Alabama
- +128 more
Feb 23, 2022
Episodic Migraine Trial in Worldwide (Erenumab, Oral Prophylactic)
Active, not recruiting
- Episodic Migraine
- Erenumab
- Oral Prophylactic
-
Stanford, California
- +111 more
Nov 16, 2021
Peri-Implantitis Trial in Worldwide (2.5 mg Chlorhexidine gluconate chip)
Completed
- Peri-Implantitis
- 2.5 mg Chlorhexidine gluconate chip
-
Baltimore, Maryland
- +9 more
Aug 24, 2022
Osteoarthritis, Knee, Knee Osteoarthritis, Knee Arthritis Trial in United States (4 mL injection of Ampion, 4 mL Injection of
Completed
- Osteoarthritis, Knee
- +3 more
- 4 mL injection of Ampion
- 4 mL Injection of Placebo
-
Birmingham, Alabama
- +12 more
Aug 8, 2022
Peripheral Artery Disease, Vascular Disease Trial in Worldwide (Gore VIABAHN Endoprosthesis)
Completed
- Peripheral Artery Disease
- Vascular Disease
- Gore VIABAHN Endoprosthesis
-
Miami, Florida
- +22 more
Apr 6, 2022
Cervical Spine Fusion Trial (Anatase Spine Surgery Navigation System)
Not yet recruiting
- Cervical Spine Fusion
- Anatase Spine Surgery Navigation System
- (no location specified)
Nov 1, 2023
Optimal Strategy for Repair of Type A Acute Aortic Dissection
Not yet recruiting
- Aortic Dissection
- Conservative TAAAD-R
- Extensive TAAAD-R
- (no location specified)
Jun 20, 2023
Repair Versus Non-repair of Aortic Arch in Type A Aortic
Enrolling by invitation
- Aortic Dissection
- +3 more
- Conservative TAAD-R
- Extensive TAAD- R
-
Saint-Denis, FranceFrancesco Nappi
Jun 20, 2023
Breast Cancer Trial in Beijing (Al18F-NOTA-FAPI-04 PET/CT scan)
Recruiting
- Breast Cancer
- Al18F-NOTA-FAPI-04 PET/CT scan
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 10, 2022
Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS) Trial in France, United States (Sutimlimab)
Recruiting
- Cold Agglutinin Disease (CAD)
- Cold Agglutinin Syndrome (CAS)
-
Birmingham, Alabama
- +7 more
Mar 28, 2023
Early Feeding Trial in Chon Buri (Food)
Recruiting
- Early Feeding
- Food
-
Chon Buri, ThailandChuenrutai Yeekian
Jul 13, 2023
Magnetic Resonance Imaging, Chronic Kidney Diseases Trial in Beijing (Polysaccharide superparamagnetic ferric oxide injection)
Not yet recruiting
- Magnetic Resonance Imaging
- Chronic Kidney Diseases
- Polysaccharide superparamagnetic ferric oxide injection
-
Beijing, Beijing, ChinaBeijing Chaoyang Hospital, Capital Medical University
Jan 16, 2023